EVE SPEICHER: Open Payments
NPI 1811477714 · NEWTON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,259 in 83 payments from 14 companies in 2025. Trend: 2023 $361 · 2024 $867 · 2025 $1,259
Food & beverage: $1,259
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 15 | $239 |
| Lilly USA, LLC | 13 | $199 |
| ABBVIE INC. | 17 | $184 |
| PFIZER INC. | 10 | $173 |
| GlaxoSmithKline, LLC. | 6 | $107 |
| AstraZeneca Pharmaceuticals LP | 5 | $81 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $68 |
| Merck Sharp & Dohme LLC | 3 | $53 |
| Axsome Therapeutics, Inc. | 3 | $51 |
| Janssen Pharmaceuticals, Inc | 2 | $30 |
Products named: Wegovy, MOUNJARO, JARDIANCE, PREVNAR 20, BREZTRI, QULIPTA, UBRELVY, CAPLYTA.
Industry payments across NJ — which companies pay providers there.
